It looks like you're offline.
Open Library logo
additional options menu

MARC Record from marc_columbia

Record ID marc_columbia/Columbia-extract-20221130-009.mrc:48466688:3352
Source marc_columbia
Download Link /show-records/marc_columbia/Columbia-extract-20221130-009.mrc:48466688:3352?format=raw

LEADER: 03352mam a2200469 a 4500
001 4047103
005 20221027024101.0
008 941103s1995 dcua b 001 0 eng c
010 $a 94043303
020 $a0309051894
035 $a(OCoLC)ocm31608452
035 $9AKL5948HS
035 $a(NNC)4047103
035 $a4047103
040 $aDNLM/DLC$cDLC$dNLM$dEYE$dCPL$dOrLoB-B
043 $an-us---
050 00 $aRA418.5.M4$bS68 1995
060 10 $aW1$bME342f v.5 1994
060 10 $aW 20.5$bS724 1994
082 00 $a610/.72$220
245 00 $aSources of medical technology :$buniversities and industry /$cNathan Rosenberg, Annetine C. Geligns, and Holly Dawkins, editors ; Committee on Technological Innovation in Medicine, Institute of Medicine.
260 $aWashington, D.C. :$bNational Academy Press,$c1995.
300 $axii, 240 pages :$billustrations ;$c23 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aMedical innovation at the crossroads ;$vv. 5
500 $a"Proceedings of the fifth workshop in the series 'The University-Industry Interface and Medical Innovation,' held in Stanford, California, on February 21-23, 1993"--T.p. verso.
504 $aIncludes bibliographical references and index.
505 00 $g1.$tThe Changing Nature of Medical Technology Development /$rAnnetine C. Gelijns and Nathan Rosenberg --$g2.$tRecent Trends in Support for Biomedical Research and Development /$rEnriqueta C. Bond and Simon Glynn --$g3.$tPhysicians and Physicists: the Interdisciplinary Introduction of the Laser to Medicine /$rJoanne Spetz --$g4.$tFrom the Scalpel to the Scope: Endoscopic Innovations in Gastroenterology, Gynecology, and Surgery /$rAnnetine C. Gelijns and Nathan Rosenberg --$g5.$tCochlear Implantation: Establishing Clinical Feasibility, 1957-1982 /$rStuart S. Blume --$g6.$tInnovation in Cardiac Imaging /$rStan N. Finkelstein, Kevin Neels and Gregory K. Bell --$g7.$tIncentives and Focus in University and Industrial Research: the Case of Synthetic Insulin /$rScott Stern --$g8.$tThe Division of Innovative Labor in Biotechnology /$rAshish Arora and Alfonso Gambardella --$g9.$tPerspectives on Industrial R & D Management /$rGerald D. Laubach --
505 80 $g10.$tThe Intertwining of Public and Proprietary in Medical Technology /$rRichard R. Nelson.
650 0 $aMedical innovations.$0http://id.loc.gov/authorities/subjects/sh85082946
650 0 $aMedicine$xResearch.$0http://id.loc.gov/authorities/subjects/sh85083097
650 12 $aDiffusion of Innovation.$0https://id.nlm.nih.gov/mesh/D004059
650 12 $aMedical Laboratory Science.$0https://id.nlm.nih.gov/mesh/D013677
650 22 $aResearch Support as Topic.$0https://id.nlm.nih.gov/mesh/D012109
651 2 $aUnited States.$0https://id.nlm.nih.gov/mesh/D014481
700 1 $aGelijns, Annetine.$0http://id.loc.gov/authorities/names/n86084084
700 1 $aRosenberg, Nathan.$0http://id.loc.gov/authorities/names/n85194242
700 1 $aDawkins, Holly V.$0http://id.loc.gov/authorities/names/n94800718
710 2 $aInstitute of Medicine (U.S.).$bCommittee on Technological Innovation in Medicine.$0http://id.loc.gov/authorities/names/n89137709
830 0 $aMedical innovation at the crossroads ;$vv. 5.$0http://id.loc.gov/authorities/names/n88525153
852 00 $boff,hsl$hRA418.5.M4$iS68 1995